# Ixmyelocel-T Treatment of Patients With Osteonecrosis of the Femoral Head

> **NCT00505219** · PHASE3 · COMPLETED · sponsor: **Vericel Corporation** · enrollment: 11 (actual)

## Conditions studied

- Osteonecrosis

## Interventions

- **BIOLOGICAL:** Ixmyelocel-T
- **OTHER:** Standard of Care Only

## Key facts

- **NCT ID:** NCT00505219
- **Lead sponsor:** Vericel Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2010-09
- **Final completion:** 2010-12
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2019-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00505219

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00505219, "Ixmyelocel-T Treatment of Patients With Osteonecrosis of the Femoral Head". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00505219. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*